UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Pharmacokinetics and PET imaging properties of two recombinant anti-PSMA antibody fragments in comparison to their parental antibody

The Prostate, 2014-05, Vol.74 (7), p.743-755

2014

Volltextzugriff (PDF)

Three conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancer

The Prostate, 2010-04, Vol.70 (5), p.562-569

2010

Volltextzugriff (PDF)

Biorecognition and Subcellular Trafficking of HPMA Copolymer−Anti-PSMA Antibody Conjugates by Prostate Cancer Cells

Molecular pharmaceutics, 2009-06, Vol.6 (3), p.959-970

2009

Volltextzugriff (PDF)

Effective targeting of prostate cancer by lymphocytes redirected by a PSMA × CD3 bispecific single-chain diabody

The Prostate, 2011-05, Vol.71 (6), p.588-596

2011

Volltextzugriff (PDF)

A new generation of monoclonal and recombinant antibodies against cell-adherent prostate specific membrane antigen for diagnostic and therapeutic targeting of prostate cancer

The Prostate, 2006-09, Vol.66 (13), p.1359-1370

2006

Volltextzugriff (PDF)

Prostate-Cancer-Targeted N-(2-Hydroxypropyl)methacrylamide Copolymer/Docetaxel Conjugates

Macromolecular bioscience, 2012-03, Vol.12 (3), p.412-422

2012

Volltextzugriff (PDF)

Activation of RhoA,B,C by Yersinia Cytotoxic Necrotizing Factor (CNFy) induces apoptosis in LNCaP prostate cancer cells

Toxins, 2013-11, Vol.5 (11), p.2241-2257

2013

Volltextzugriff (PDF)

Anti-PSMA immunotoxin as novel treatment for prostate cancer? High and specific antitumor activity on human prostate xenograft tumors in SCID mice

The Prostate, 2008-02, Vol.68 (2), p.129-138

2008

Volltextzugriff (PDF)

Non-invasive in vivo imaging of tumor-associated CD133/prominin

PloS one, 2010-12, Vol.5 (12), p.e15605

2010

Volltextzugriff (PDF)

Influence of Structural Variations on Biological Activity of Anti-PSMA scFv and Immunotoxins Targeting Prostate Cancer

Anticancer research, 2010-09, Vol.30 (9), p.3373-3379

2010

Volltextzugriff (PDF)

High-resolution animal PET imaging of prostate cancer xenografts with three different 64Cu-labeled antibodies against native cell-adherent PSMA

The Prostate, 2010-09, Vol.70 (13), p.1413-1421

2010

Volltextzugriff (PDF)

Targeted therapies for prostate cancer against the prostate specific membrane antigen

Current drug targets, 2009-02, Vol.10 (2), p.118

2009

Volltextzugriff (PDF)

Antitumoral effect of recombinant mistletoe lectin on chemically induced urinary bladder carcinogenesis in a rat model

Cancer, 2001-03, Vol.91 (5), p.998-1004

2001

Volltextzugriff (PDF)

PET Imaging of Prostate Cancer Xenografts with a Highly Specific Antibody against the Prostate-Specific Membrane Antigen

Journal of Nuclear Medicine, 2009-04, Vol.50 (4), p.606-611

2009

Volltextzugriff (PDF)

Pseudomonas exotoxin A: From virulence factor to anti-cancer agent

International journal of medical microbiology, 2009-03, Vol.299 (3), p.161-176

2009

Volltextzugriff (PDF)

Comparison of the activation status of tumor infiltrating and peripheral lymphocytes of patients with adenocarcinomas and benign hyperplasia of the prostate

The Prostate, 2000-09, Vol.45 (1), p.1-7

2000

Volltextzugriff (PDF)

Primary prostate cancer cultures are models for androgen-independent transit amplifying cells

Oncology reports, 2010-02, Vol.23 (2), p.465-470

2010

Volltextzugriff (PDF)

Effective Eradication of Glioblastoma Stem Cells by Local Application of an AC133/CD133-Specific T-cell-Engaging Antibody and CD8 T Cells

Cancer research (Chicago, Ill.), 2015-06, Vol.75 (11), p.2166-2176

2015

Volltextzugriff (PDF)

Cytokine levels in whole blood cell cultures as parameters of the cellular immunologic activity in patients with malignant melanoma and basal cell carcinoma

Cancer, 1993-01, Vol.71 (1), p.231-236

1993

Volltextzugriff (PDF)

Pharmacokinetics and PET imaging properties of two recombinant anti-PSMA antibody fragments in comparison to their parental antibody: Imaging of Prostate Tumors

The Prostate, 2014-05, Vol.74 (7), p.743-755

2014

Volltextzugriff (PDF)

Pseudomonas Exotoxin A‐Based Immunotoxins for Targeted Cancer Therapy

Emerging Cancer Therapy, 2010, p.269-288

2010

Volltextzugriff (PDF)

Antitumor activities of PSMA×CD3 diabodies by redirected T-cell lysis of prostate cancer cells

Immunotherapy, 2013-01, Vol.5 (1), p.27-38

2013

Volltextzugriff (PDF)

Preclinical evaluation of a recombinant anti-prostate specific membrane antigen single-chain immunotoxin against prostate cancer

Journal of immunotherapy, 2010-04, Vol.33 (3), p.262-271

2010

Volltextzugriff (PDF)

Bispecific antibodies and diabodies for cancer immunotherapy

Immunotherapy, 2012-05, Vol.4 (5), p.459-460

2012

Volltextzugriff (PDF)

Target-dependent T-cell activation by coligation with a PSMA x CD3 diabody induces lysis of prostate cancer cells

Journal of immunotherapy (1997), 2009-07, Vol.32 (6), p.565

2009

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(46)
Buchkapitel
(2)

Sprache

Englisch
(47)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(33)
Science & Technology
(33)
Life Sciences & Biomedicine
(32)
Male
(28)
Biological And Medical Sciences
(21)
Medical Sciences
(21)
Prostate Cancer
(17)
Tumors
(15)
Nephrology. Urinary Tract Diseases
(14)
Oncology
(14)
Tumors Of The Urinary System
(14)
Animals
(13)
Cell Line, Tumor
(13)
Prostatic Neoplasms - Immunology
(11)
Urinary Tract. Prostate Gland
(11)
Antigens, Surface - Immunology
(10)
Glutamate Carboxypeptidase Ii - Immunology
(10)
Immunotherapy
(10)
Mice
(10)
Aged
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacokinetics and PET imaging properties of two recombinant anti-PSMA antibody fragments in comparison to their parental antibody

Three conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancer

Biorecognition and Subcellular Trafficking of HPMA Copolymer−Anti-PSMA Antibody Conjugates by Prostate Cancer Cells

Effective targeting of prostate cancer by lymphocytes redirected by a PSMA × CD3 bispecific single-chain diabody

A new generation of monoclonal and recombinant antibodies against cell-adherent prostate specific membrane antigen for diagnostic and therapeutic targeting of prostate cancer

Prostate-Cancer-Targeted N-(2-Hydroxypropyl)methacrylamide Copolymer/Docetaxel Conjugates

Activation of RhoA,B,C by Yersinia Cytotoxic Necrotizing Factor (CNFy) induces apoptosis in LNCaP prostate cancer cells

Anti-PSMA immunotoxin as novel treatment for prostate cancer? High and specific antitumor activity on human prostate xenograft tumors in SCID mice

Non-invasive in vivo imaging of tumor-associated CD133/prominin

Influence of Structural Variations on Biological Activity of Anti-PSMA scFv and Immunotoxins Targeting Prostate Cancer

High-resolution animal PET imaging of prostate cancer xenografts with three different 64Cu-labeled antibodies against native cell-adherent PSMA

Targeted therapies for prostate cancer against the prostate specific membrane antigen

Antitumoral effect of recombinant mistletoe lectin on chemically induced urinary bladder carcinogenesis in a rat model

PET Imaging of Prostate Cancer Xenografts with a Highly Specific Antibody against the Prostate-Specific Membrane Antigen

Pseudomonas exotoxin A: From virulence factor to anti-cancer agent

Comparison of the activation status of tumor infiltrating and peripheral lymphocytes of patients with adenocarcinomas and benign hyperplasia of the prostate

Primary prostate cancer cultures are models for androgen-independent transit amplifying cells

Effective Eradication of Glioblastoma Stem Cells by Local Application of an AC133/CD133-Specific T-cell-Engaging Antibody and CD8 T Cells

Cytokine levels in whole blood cell cultures as parameters of the cellular immunologic activity in patients with malignant melanoma and basal cell carcinoma

Pharmacokinetics and PET imaging properties of two recombinant anti-PSMA antibody fragments in comparison to their parental antibody: Imaging of Prostate Tumors

Pseudomonas Exotoxin A‐Based Immunotoxins for Targeted Cancer Therapy

Antitumor activities of PSMA×CD3 diabodies by redirected T-cell lysis of prostate cancer cells

Preclinical evaluation of a recombinant anti-prostate specific membrane antigen single-chain immunotoxin against prostate cancer

Bispecific antibodies and diabodies for cancer immunotherapy

Target-dependent T-cell activation by coligation with a PSMA x CD3 diabody induces lysis of prostate cancer cells

Suchergebnisse filtern